| Identification | More | [Name]
1H-Benzimidazole-5-carboxylic acid | [CAS]
15788-16-6 | [Synonyms]
1H-BENZIMIDAZOLE-5-CARBOXYLIC ACID
1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID
5-BENZIMIDAZOLECARBOXYLIC ACID
5-CARBOXYBENZIMIDAZOLE
AKOS BBS-00000435
AURORA 9842
BENZIMIDAZOLE-5-CARBOXYLIC ACID
BENZOIMIDAZOLE-5-CARBOXYLIC ACID
OTAVA-BB BB7014211630
3H-benzo[d]imidazole-5-carboxylic acid
1H-Benzimidazole-5-carboxylicacid(9CI)
5-Carboxylic Acid Benzimidazole
1H-Benzimadazole-5-carboxylic acid
1H-benzimidazole-6-carboxylic acid
1H-Benzoimidazole-6-carboxylic acid | [Molecular Formula]
C8H6N2O2 | [MDL Number]
MFCD00011555 | [Molecular Weight]
162.15 | [MOL File]
15788-16-6.mol |
| Chemical Properties | Back Directory | [Appearance]
GREEN-GREY TO GREY-BROWN POWDER | [Melting point ]
>300 °C (lit.) | [Boiling point ]
288.82°C (rough estimate) | [density ]
1.3264 (rough estimate) | [refractive index ]
1.5770 (estimate) | [storage temp. ]
Keep in dark place,Sealed in dry,Room Temperature | [solubility ]
DMSO (Slightly), Methanol (Slightly, Heated) | [form ]
Powder | [pka]
3.10±0.30(Predicted) | [color ]
Green-gray to gray-brown | [BRN ]
5686 | [InChIKey]
COYPLDIXZODDDL-UHFFFAOYSA-N | [CAS DataBase Reference]
15788-16-6(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S37/39:Wear suitable gloves and eye/face protection . | [WGK Germany ]
3
| [HazardClass ]
IRRITANT | [HS Code ]
29339900 |
| Hazard Information | Back Directory | [Chemical Properties]
GREEN-GREY TO GREY-BROWN POWDER | [Uses]
5-Benzimidazolecarboxylic acid has been used in the preparation of:
- 1H-benzoimidazole-5-carboxylic acid benzotriazol-1-yl ester
- piperidin-1-yl(1-m-tolyl-1H-benzo[d]imidazol-5-yl)methanone
| [Uses]
A benzimidazole derivative that exhibits corrosion inhibiting properties against strong acids. | [General Description]
Drug-specific monoclonal antibodies were produced against the very small drug hapten, 5-benzimidazolecarboxylic acid. |
|
|